Board of Directors
Michael Ingram
Board Member
Biography
Dr. Michael Ingram is a double board-certified psychiatrist with expertise in a wide range of neuropsychiatric disorders. He holds board certifications in General Psychiatry and Consultation-Liaison Psychiatry (formerly Psychosomatic Medicine), a sub-specialty that bridges the gap between mental and physical health. Part of his training includes psycho-oncology, which explores the emotional and psychological challenges associated with a cancer diagnosis.
He manages a private practice in Los Angeles, CA and is actively involved in medical education, mentoring and supervising residents, medical students, and midlevel providers. His work extends beyond the office, as he serve as a consultant for medical hospitals, intensive outpatient programs (IOPs), partial hospitalization programs (PHPs), and law firms providing recommendations for managing patients with complex neuropsychiatric conditions, ensuring their care is both comprehensive and compassionate.
In his free time, he enjoys staying active through biking, golfing, and basketball. He also enjoys reading and writing. Above all, he cherishes spending time with his wife Katie, their son Mico, and their two beloved cats, Marvel and Jax. He is honored to be part of this initiative that focuses on supporting the lives of those impacted by gallbladder cancer.
How has cancer impacted your family and/or friends?
Both of my parents were impacted by cancer. In 2008, my mother was diagnosed with colon cancer. Luckily, she caught it early and curative surgery spared her from needing chemotherapy. Just two years later, in 2010, we were blindsided—this time, it was my father. His journey was far more grueling, involving not just surgery but rounds of chemotherapy that drained his energy and transformed his body and mind in ways I hadn’t expected. Watching my father, once so full of vigor, a Vietnam veteran and cardiac surgeon, endure the ravages of treatment was both heart-wrenching and profoundly humbling. These experiences left a mark on me. But I am eternally grateful as many aren’t as fortunate. These experiences have forced me to confront life’s fragility and unpredictability, reshaping how I view relationships, priorities, and the value of simply being alive. But the most meaningful takeaway is something I share with my patients: to never lose hope.
Jimmy Kumar
Board Member
Biography
Jimmy Kumar is a seasoned business management professional with over 15 years of experience in overseeing various facets of operations, from sales and customer service to team management and business development. He currently serves as the General Manager at Bud Polley’s Floor Center, where his dynamic leadership has been instrumental in driving the company’s growth and operational efficiency. In his role, Jimmy manages a diverse team of over 30 individuals, bringing together consultants, sales professionals, and installation experts to create a seamless experience for customers.
His ability to balance multiple responsibilities and cultivate a collaborative work environment is a key strength, and it is reflected in his day-to-day operations. Jimmy has a deep understanding of consulting, tertiary sector, customer service, human resources, recruiting top talent, training new employees, and business to business development. All of which contribute to fostering an environment where individuals can thrive and contribute to the organization’s success. Connecting with partners, suppliers, stakeholders, and employees forging mutually beneficial relationships that support the growth of the company, and interpersonal relationships simultaneously.
How has cancer impacted your family and/or friends?
The first time I heard of cancer, I was just 8 years old, sitting in my father’s office, staring at a photo I believed was of me. Yet, I had no memory of ever having taken it. That was when my father’s secretary gently shared the heartbreaking news about Ranjeev, an older brother I never knew I had, who had passed away from Leukemia at the age of 6, two years before I was born. Since that moment, the number of people I’ve known affected by cancer has grown exponentially. One of the most significant and recent experiences was my mother’s battle with gallbladder cancer in 2022 (https://gallbladdercancer.org/patient-journey/).
Cancer has touched nearly every corner of my life, across the five major categories—Carcinoma, Sarcoma, Leukemia, Myeloma, and Lymphomas—claiming the lives of many dear friends and family members. Watching my older brother Sanjeev’s journey has been nothing short of inspiring. From his own experience at age 1, when he underwent bone marrow extraction in a desperate attempt to save Ranjeev’s life, to becoming a Associate Director at Nohla Therapeutics, where he worked on regenerative cell therapies for Leukemia, it has been a powerful full-circle moment.
After our mother’s gallbladder cancer diagnosis, Sanjeev took it a step further, founding the Gallbladder Cancer Foundation. His mission is to create proper resources for those battling this disease—both past and present. We often reflect on how different life might have been with Ranjeev, but one thing I know for certain: He would be incredibly proud of you, Sanjeev.
I’m excited to be part of this new foundation and look forward to joining forces in the fight to find cures for gallbladder cancer.
Sanjeev Kumar
Chairman
Founder, President, & CEO
Interim Secretary
Biography
Sanjeev Kumar holds a Bachelor’s degree in Molecular and Cell Biology with a concentration in Immunology and Pathogenesis from the University of California, Berkeley, awarded in 2010.
In 2011, he commenced his professional career at Dendreon Corporation, where he manufactured Provenge, the world’s first FDA-approved autologous cellular immunotherapy for asymptomatic or minimally symptomatic metastatic castrate-resistant prostate cancer. Subsequently, he transitioned to Process Engineering, as a Provenge subject matter expert and served as a liaison between Research and Development and the Commercial Immunotherapy Manufacturing Facilities. Sanjeev actively participated in numerous process improvement initiatives and technology transfers.
In 2017, he joined a biotech startup called Nohla Therapeutics as the Manager of Clinical Manufacturing. During his tenure at Nohla, he spearheaded the development and management of the clinical manufacturing operations, overseeing the Phase II multi-dose manufacturing of NLA-101, an allogeneic expanded CD34+ stem cell therapy derived from umbilical cord blood, for the treatment of acute myeloid leukemia (AML) patients with chemotherapy-induced neutropenia. In recognition of his contributions, he was promoted to Associate Director of Manufacturing in 2018.
In November 2022, Sanjeev’s mother was diagnosed with Stage 4 gallbladder cancer. During her treatment, he noticed that there weren’t many organized resources and support available to gallbladder cancer patients. Inspired by the work of Stacie Lindsey and the Cholangiocarcinoma Foundation he founded the Gallbladder Cancer Foundation in January 2024.
How has cancer impacted your family and/or friends?
Cancer has had a big impact on our family. My older brother, Ranjeev, was diagnosed with leukemia when he was 5 years old and in kindergarten. I was a baby and only one year old at the time. In an attempt to save my brother, the hospital took bone marrow from me since I was a related match, but unfortunately, the bone marrow transplant did not work. My older brother passed away when he was 6 years old. I never got the chance to get to know my older brother, and the loss of a child devastated my mother and father. My younger brother, Jimmy, was born a few years later so I was fortunate to still get a chance to grow up with a brother. However, Jimmy and I have always wondered how different our lives would have been if our older brother was still alive.
In November 2022, my mother was diagnosed with Stage 4 gallbladder cancer. Helping her through her journey, I’ve seen how challenging it can be for someone to go through treatment and fight an aggressive cancer. My mom was fortunate to have a rare mutation and is MSI-High. She responded well to immunotherapy and has been in complete remission since September 2023. Our family has been fortunate to be able to continue to form new memories with her. I still think about how different things could have been if my mom was not MSI-High or if checkpoint inhibitor immunotherapies did not exist. I thought about all the other patients battling this rare and aggressive cancer and the toll it takes on their families. I wanted to help other patients & caregivers and work towards finding cures for gallbladder cancer, which is why I started the Gallbladder Cancer Foundation.
Scott Lieberman
Board Member
Treasurer
Biography
Scott Lieberman is an AVP on the Strategic Partners Team at LPL Financial, where he spearheads data monetization initiatives and oversees more than 30 sponsor relationships. Before joining LPL Financial, he held positions in Information Technology and Human Resources at TIAA.
Mr. Lieberman holds a Bachelor of Science in Business Administration from the University of North Carolina at Charlotte and a Master of Science in Leadership from Northeastern University. He is also a member of the University of North Carolina at Charlotte alumni board of directors.
In his free time, Scott enjoys attending sporting events, playing golf, and traveling. He is deeply passionate about raising awareness for gallbladder cancer, a cause close to his heart since his mother, Mona, was diagnosed in June 2021 and passed away in March 2022.
How has cancer impacted your family and/or friends?
My grandfather passed away from colon cancer when I was young. While it didn’t impact me directly, seeing its effect on my mom inspired me to get involved with cancer charities. In high school, my mom was diagnosed with ovarian cancer and underwent a hysterectomy. That was my last direct experience with cancer until June 2021, when my life changed forever.
My mom, Mona, went in for a routine gallbladder removal surgery, and unfortunately, they discovered stage 4 gallbladder cancer. We immediately consulted specialists in our area, who gave her nine months to live. She bravely underwent chemotherapy and fought every single day, living life to the fullest on both good and bad days. Sadly, the prognosis was accurate, and she passed away in March 2022, exactly nine months after her diagnosis.
I miss my mom every day and want to honor her legacy by being part of the first charity dedicated specifically to gallbladder cancer.
Alex Quinn
Board Member
Biography
How has cancer impacted your family and/or friends?
Cancer took away my dear cousin, David, who passed away from leukemia at age 20. He was in the middle of his studies at Chapman University and on his way to becoming a star documentary film producer. He passed away in 2006, and I often think about what stories the world has missed without him here to tell them.